Trial results and implications for diabetes care A new oral glucagon like peptide 1 (GLP 1) receptor agonist pill reported better outcomes than an existing oral option in people with type 2 diabetes. In head to head findings, the experimental agent produced g…
A new oral glucagon-like peptide-1 (GLP-1) receptor agonist pill reported better outcomes than an existing oral option in people with type 2 diabetes. In head-to-head findings, the experimental agent… [+1592 chars]
